That's essential, because the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we have to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental process (brownstone research stock). But now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a breakthrough almost nobody observed. However it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be lots of financial investment opportunities in this area, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (what is the legacy report predicting). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly considerably prior to going higher - white house. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were primarily informing readers. But that's not the huge concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. last week. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so numerous terrific private companies on the brink of striking the general public markets And I have actually been working on a brand-new way for you to invest even before these business go public.
This chance has actually been constructing over the last few years. I can't wait to tell you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the information. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Journal. Regular Diary readers know that tech isn't our usual beat (jeff brown investor prediction). And when it concerns tech investing, we leave it to the specialists. The good news is, we have numerous such specialists in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we understand (bleeding edge). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These patterns are experiencing exponential growth and creating extraordinary chances for financiers. I want to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. jeff brown investor prediction. However in spite of what numerous readers may believe, this is a trend that's simply beginning. Despite the fact that the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled devices were still offered.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (longtime readers). Losing 2 months of manufacturing and sales truly impacts the number of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million units is exceptional. More significantly, the hold-ups caused by the pandemic produced a lots of suppressed demand. And that demand is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - jeff brown stock predictions 2021. And that's not my only 5G prediction When I've spoken about 5G in the past, I've explained its three various stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage 3, 5G services begin to be used (jeff brown biotech genome sequencing). That's when we start to see applications operating on 5G networks. Think of things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage Three by this summertime. This begins something of a virtuous cycle: The majority of people don't actually care about the technology. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being established. In reality, 5G is going to open up a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these technologies need 5G. The financial investment opportunities moving forward will be huge. Stepping away from 5G, the next important technology I predict in 2021 is CRISPR hereditary modifying. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR uses a comparable idea however with our hereditary code. "Typos" in our genome can lead to illness. CRISPR can remedy these "typos." For many years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were actually just three business operating in this area. But things are altering. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This entire market is effectively a greenfield opportunity.
There's space for numerous companies to exist in this space. exponential tech investor. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that 2 or 3 more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software application can accurately predict the folding of a protein based exclusively on its amino acid sequence with 92. 4% precision. That is essential because the method a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been an experimental process. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug therapies produced utilizing this technology. This was one of those advancements that nearly no one noticed. But it's going to have extensive ramifications for curing disease. And, naturally, there will be a lot of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe substantially prior to going higher. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever published was on bitcoin - future report review. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that preliminary suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. self-driving cars. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date since February 2021, but we might not individually verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to select winning technology stocks. He invested more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional viewpoint on the market. He's constantly on the hunt for brand-new chances, and he shares many of his finest picks in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully anticipated a few of the biggest economic occasions of the previous twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it ideal each time, however Jeff Brown's precise forecasts have made him legions of dedicated fans. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research study uses a number of research services with a large range of specializations - jeff brown biotech picks.
The company is also connected with Bonner & Partners, another well-respected research publisher - last week. On its site, Brownstone states its objective is to offer retail financiers with professional-grade research study: "For too long, the finest financial investment research study has not been offered to individual financiers. It has actually been generally booked for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown biotech genome sequencing. The objective of Brownstone Research is to make that kind of exclusive research study readily available to any financiers aiming to get an edge in the markets. The goal is easy to provide unique and lucrative financial investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the company's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you know even a little bit about the market, you know that he has a reputation as a King Midas of sorts. black sea. Everything he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown thinks S.A.V. jeff bezos. might be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 cutting-edge innovations: synthetic intelligence and electric vehicles. Musk hopes the combination will help him establish the first fully-autonomous, self-driving cars ever. It's absolutely nothing short of the automotive industry's Holy Grail. As you understand, electric vehicles and self-driving car stocks have been substantial this year, but the Wall Street device has been big on buzz without much concrete outcome. Despite a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the finest possibility of putting all of it together.
tech could be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Car, and it could be the future of transport. Generally, this innovation would allow you to rent your automobile as a self-governing, self-driving taxi when you're not using it. You simply get out of the vehicle and press a button on an app that tells the vehicle to "join the fleet." Next thing you understand, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a substantial portion of the revenues. It sounds ridiculous, but it could be closed than you think.